Trial Profile
Randomized Controlled Pilot Study of Highly Active Anti-Retroviral Therapy for Patients With Primary Biliary Cirrhosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lopinavir/ritonavir (Primary)
- Indications Biliary cirrhosis
- Focus Pharmacodynamics
- Acronyms HAART
- 01 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Dec 2014 Planned End Date changed from 1 Sep 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 02 Dec 2014 Planned primary completion date changed from 1 Sep 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.